DUPHAT 2026 Speakers

Prof. Gary C. Yee

Pharm.D., FCCP, Professor Emeritus, Department of Pharmacy Practice and Science University of Nebraska Medical Center | USA

Dr. Gary Yee is professor emeritus at the College of Pharmacy, University of Nebraska Medical Center in Omaha, Nebraska. He completed his B.S. degree in Pharmacy at the University of Washington, his Pharm.D. at the Philadelphia College of Pharmacy and Science, and residency and fellowship at St. Jude Children's Research Hospital. He is a fellow of the American College of Clinical Pharmacy and the American Pharmacists Association. Before UNMC, he held positions at the Fred Hutchinson Cancer Research Center and the University of Florida. At UNMC, he has served as department chair, associate dean for academic affairs and associate vice chancellor for academic affairs. He also completed a sabbatical at the Leonard Davis Institute of Health Economics at the University of Pennsylvania. Dr. Yee has been involved in oncology practice, education, and research for more than 40 years and was board certified in oncology from 2006 to 2019. He first became interested in oncology while working in a research laboratory at the University of Washington. He has published more than 100 publications in peer-reviewed journals and his research findings have been published in several prominent medical journals, including first author publications in the New England Journal of Medicine and the Lancet. Dr. Yee was also one of the editors of Pharmacotherapy: A Pathophysiologic Approach (DiPiro). His research has been supported by numerous sources, including the National Institutes of Health. He has served as a member of guideline panels of several professional oncology groups, including the American Society of Clinical Oncology and National Comprehensive Cancer Network. Dr. Yee has served as an elected officer for several professional organizations and is a past president of the American College of Clinical Pharmacy and a past chair of the Board of Pharmacy Specialties. He has received the American College of Clinical Pharmacy Robert M. Elenbaas Service Award"

Prof. Joseph T. DiPiro

Professor Emeritus School of Pharmacy, Virginia Commonwealth University" | USA

Dr. DiPiro received his B.S. in Pharmacy (Honors College) from the University of Connecticut and Doctor of Pharmacy from the University of Kentucky. He completed a residency at the University of Kentucky Medical Center and a fellowship in Clinical Immunology at Johns Hopkins University. He served on the Faculty of the University of Georgia College of Pharmacy for 24 years, as Executive Dean at the South Carolina College of Pharmacy from 2005 to 2014 and Dean at Virginia Commonwealth University from 2014 to 2022. He is Past-President of the American Association of Colleges of Pharmacy and Past Chair of the Council of Deans. He has served as President of the American College of Clinical Pharmacy. He is a Fellow of the College and has served on the Research Institute Board of Trustees. He has been a member of the American Society of Health-System Pharmacists, having served on the Commission on Therapeutics and the Task Force on Science. Dr. DiPiro was elected a Fellow in the American Association for the Advancement of Science. At present, Dr. DiPiro is serving as a Consultant to ACPE for the International Services Program. Dr. DiPiro was editor for Pharmacotherapy: A Pathophysiologic Approach for 12 editions, and the ASHP Pharmacy Forecast for 6 years. He served as Editor of The American Journal of Pharmaceutical Education for 12 years. He is also the author of Concepts in Clinical Pharmacokinetics and Editor of the Encyclopedia of Clinical Pharmacy. He has published over 250 journal papers, books, book chapters, and editorials in academic and professional journals"

Mr. Klaus Meier

President European Society of Oncology Pharmacy (ESOP) Global | Germany

Mr. Klaus Meier Director - Institute for Applied Healthcare Sciences (IFAHS) Veritaskai 6, D – 21079 Hamburg Klaus Meier studied theology with the master in 1975, has finished as candidate studies of paedagogics 1975 and the studies of pharmacy in 1981 with the approbation from the ministry of health in Kiel."

Prof. María Blanco Prieto

Professor, University of Navarra Spain | Spain

María Blanco Prieto obtained her Pharmacy Degree from the University of Santiago de Compostela (Spain) and later completed a PhD in Pharmaceutical Sciences at the University of Paris-Sud (France). She subsequently underwent post-doctoral training at the Swiss Federal Institute of Technology (ETH) in Zürich, Switzerland. She then joined the University of Navarra, where she currently holds the position of Full Professor of Pharmacy and Pharmaceutical Technology. Throughout her career, she has authored over 180 research papers and book chapters, which have garnered more than 11,500 citations (H-index 62). Additionally, she has written 6 editorials, obtained 5 patents, and presented over 230 communications at scientific conferences, often as an invited speaker. She has also led more than 38 competitive research projects and served as an expert for the European Commission in the field of nanomedicines and drug delivery. Her research focuses on the development of nanomedicines for cancer treatment (particularly childhood cancer), as well as tissue regeneration of the heart and brain through tissue engineering. Her contributions to drug delivery research have been recognized with numerous national and international awards. Among other recognitions, she is a member of the National Academy of Pharmacy of France and the Academy of Galicia. From 2020 to March 2024, she served as President of the Spanish Society of Industrial Pharmacy and Galenic (SEFIG). In 2021, she became a member of the College of Fellows of the American Institute of Medical and Biological Engineering (AIMBE), one of the most important associations in the biomedical engineering sector based in Washington DC. In 2022, she was elected as a member of the Academia Europaea, and in 2024, she became a member of the Academy of Medicine of France. Since January 2023, she has served as President of the European Federation of Pharmaceutical Sciences (EUFEPS)."

Prof. Peter J. Pitts

Peter Pitts is President of the Center for Medicine in the Public Interest, a Visiting Professor at the University of Paris Medical School, an Honorary Proff. at Sefako Makgatho Health Scienc | USA

Peter Pitts is President of the Center for Medicine in the Public Interest, a Visiting Professor at the University of Paris Medical School, an Honorary Professor at Sefako Makgatho Health Sciences University (Pretoria, South Africa), and a Research Fellow at the US-Israel Education Association. He is a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration.  Pitts is a member of the Council for International Organizations of Medical Sciences (CIOMS) Expert Working Group to help advance patient involvement in the development and safe use of medicines and a member of the United States Pharmacopeia Drug Shortage Task Force. He is the author of many peer-reviewed articles appearing in publications including the Lancet, Health Affairs, Journal of the American Medical Association, NEJM Catalyst, Vaccines, Nature Biotechnology, Therapeutic Innovation and Regulatory, and the Journal of Commercial Biotechnology. He is an Associate Editor of Therapeutic Innovation & Regulatory Science (the official DIA journal), a member of the Editorial Advisory Board Journal of Commercial Biotechnology and The Patient Magazine. Pitts lives in New York City. His comments and commentaries on health care policy issues regularly appear in The New York Times, The Los Angeles Times, The Washington Post, The Wall Street Journal, The Financial Times, Health Affairs, Time, Newsweek, The Boston Globe, The Washington Times, The Chicago Tribune, The San Francisco Examiner, Investor’s Business Daily, The Baltimore Sun, The Economist, The Lancet, Nature Biotechnology, BioCentury, The Journal of Commercial Biotechnology, the BBC World Service, Fox News, CNBC, Bloomberg, The PBS NewsHour, NBC Dateline, Sky News, La Stampa. L’Opinion, The Daily Show with John Stewart, among others. He has given healthcare policy presentations throughout Europe, Canada, and the United States, as well as in Russia, China, Hong Kong, Taiwan, India, the Philippines, Malaysia, Saudi Arabia, Lebanon, Oman, Israel, Turkey, The United Arab Emirates, Kuwait, Qatar, Jordan, Kenya, South Africa, Egypt, Algeria, Ukraine, Thailand, Japan, Brazil, Mexico, Vietnam, Indonesia, Singapore, Panama, Costa Rica, Argentina, and Colombia. His new book, Prescient and Possible, focuses on the need to stand firm on the urgency of sound science. He is also the author of And Nothing but the Truth, The Next Normal, The Value Equation: A Journey Through the Innovation Ecosystem in the Time of COVID, Common-Sense Healthcare for Common Sense Americans, and Become Strategic or Die, widely recognized as a cutting- edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of Coincidence or Crisis, a discussion of global prescription medicine counterfeiting and Physician Disempowerment: A Transatlantic Malaise. "

Prof. Abeer Al-Ghananeem

B.Sc. Pharm, M.Sc., Ph.D | United Arab Emirates

Professor Abeer Al-Ghananeem, Ph.D., is a distinguished academic leader and global expert in pharmacy education, research, and innovation. She currently serves as Dean of the College of Pharmacy and Health Sciences at Ajman University in the United Arab Emirates, where she oversees three professional healthcare programs (Pharmacy, Nursing, and Physiotherapy), and champions educational excellence, interprofessional training, and the integration of emerging technologies, including artificial intelligence, into health sciences education Professor Al-Ghananeem is an Academic Leadership Fellow (ALFP) of the American Association of Colleges of Pharmacy (AACP) and a Past Chair and Commissioner of the Accreditation Council for Pharmacy Education (ACPE) International Services Program. She also serves on the Board of Trustees of the Talal Abu-Ghazaleh University College for Innovation (TAGUCI) in Jordan and is Global Lead for Quality Assurance at the International Pharmaceutical Federation (FIP). Additionally, she is an Associate Editor of the FIP Pharmacy Education Journal. She has held faculty and leadership roles at the University of Kentucky and Sullivan University, USA, before joining Ajman University. An influential contributor to national and international initiatives that bridge education, healthcare, and innovation, Professor Al-Ghananeem has led projects focused on continuous professional development and interprofessional education and has helped prepare faculty and students for the transformation of healthcare in the digital age, including the strategic integration of artificial intelligence in healthcare education and assessment.

Dr. Alaa Alquayt

Master’s degree in Clinical Pharmacy clinical pharmacist, researcher, and healthcare leader specializing in psychiatric pharmacy, clinical education, and healthcare innovation | Saudi Arabia

Dr. Alaa Badr Alquayt is a clinical pharmacist, researcher, and healthcare leader specializing in psychiatric pharmacy, clinical education, and healthcare innovation. She holds a Master’s degree in Clinical Pharmacy from King Saud University and currently serves as the Residency Program Director and Clinical Pharmacy Unit Supervisor at Eradah Complex & Mental Health, Third Health Cluster, Riyadh, Ministry of Health. In these roles, she oversees residency training, supports postgraduate professional development, and leads initiatives to enhance service delivery and patient safety. Her clinical practice and research focus on improving care for patients with serious mental illness. She has contributed to the development of specialized psychiatric pharmacy services, including protocols for the safe and effective use of high-risk medications such as clozapine. Her work emphasizes multidisciplinary collaboration, evidence-based practice, and continuous quality improvement in mental health care. Beyond psychiatry, Dr. Alquayt has advanced research in digital health and artificial intelligence. She served as the lead investigator on a national study exploring the integration of AI into healthcare services during the Hajj pilgrimage. This work, published in peer-reviewed journals, addressed the operational, ethical, and data security challenges of AI deployment in mass gatherings and proposed practical frameworks to support predictive analytics, triage, and patient care optimization. Her position as first author highlights her leadership in shaping this emerging field of practice. Dr. Alquayt is also an active contributor to multicenter research collaborations, including projects under the Saudi Critical Care Pharmacy Research (SCAPE) platform. Her academic portfolio includes peer-reviewed publications, scientific posters, and consensus papers that bridge clinical practice with health systems innovation. A dedicated mentor and educator, she has guided numerous pharmacy residents and junior clinicians, fostering a new generation of pharmacists prepared to meet evolving healthcare challenges. At DUPHAT 2026, Dr. Alaa Badr Alquayt will present on 'Depression & Anxiety – Pharmacologic Updates' and lead a workshop on 'Opioid Stewardship,' reflecting her ongoing commitment to advancing clinical pharmacy practice and improving patient outcomes across the region. "

Prof. Ali Abdullah

MPharm, MSc Head of TPN Unit, Mubarak Al-Kabeer Hospital Kuwait Pharmaceutical Association Board Member Visiting Teaching Assistant, College Of Health Science, PAAET | Kuwait

Prof. Ali Abdullah serves as the Head of the Total Parenteral Nutrition Unit in the Pharmacy Department at Mubarak Al-Kabeer Hospital, one of Kuwait’s largest and most prominent medical facilities, catering to a population exceeding 250,000. He has led teams within the department, including participation in scientific and quality control committees. RPh. Abdullah is also serving now as Board member of Kuwait Pharmaceutical Association. Additionally, he holds a position as a visiting teaching assistant in the Department of Pharmaceutical Science at the College of Health Sciences, Public Authority of Applied Education and Training. He has contributed to editing the "200 Common Drugs of Kuwait" booklet, recognized as one of the country's latest pharmaceutical references, and has co-authored several articles in collaboration with Kuwait University. RPh. Abdullah holds an MSc from King's College London, a globally renowned school of pharmacy

Dr. Ali AlTahoo

Regulatory Affairs Pharmacist and Drug Manufacturing Site Inspector at the National Health Regulatory Authority (NHRA) in the Kingdom of Bahrain" | Bahrain

Dr. Ali Ahmed AlTahoo is a Regulatory Affairs Pharmacist and Drug Manufacturing Site Inspector at the National Health Regulatory Authority (NHRA) in the Kingdom of Bahrain. His role at NHRA comes after graduating from the University of Bahrain with a Bachelor of Science in Pharmacy and gaining holistic insights on the local pharmacy field and the challenges posed in its practice through volunteering during the COVID-19 pandemic in Bahrain’s government hospitals, and formerly working as a community pharmacist. In his current role, he contributes to the oversight and regulation of pharmaceutical products and manufacturing facilities, ensuring compliance with national and international standards to safeguard public health. Ali’s responsibilities extend across a wide range of regulatory functions, including the assessment, licensing, and post-registration surveillance of medicines. He is experienced in all the processes of registering pharmaceutical products: new registration, medicine variations, and medicine license renewals. Ali also conducts local and international Good Manufacturing Practice (GMP) inspections, evaluating pharmaceutical manufacturing sites to ensure adherence to quality, safety, and e3icacy requirements. His inspection work is guided by globally recognized frameworks such as those established by the World Health Organization, the European Medicines Agency, and the Gulf Health Council. Ali aims to continuously contribute to the advancement of NHRA’s mission to enhance the quality and reliability of healthcare services in Bahrain. He has also supported the implementation of digital transformation initiatives, contributing to the development and optimization of NHRA’s electronic platform for regulatory processes related to pharmaceutical products, Adweya, designed to improve e3iciency, transparency, and stakeholder engagement across the healthcare sector. Alongside Ali’s progression in his role as a regulatory a3airs pharmacist and inspector, he is committed to his role in advocacy for pharmacists in Bahrain, with numerous scientific and societal contributions to the pharmacy sector. His contributions are mostly reflected through the Bahrain Pharmacists Society, the main body representing pharmacists in Bahrain. Ali began as a member of the society and recently advanced to its board of directors as the financial secretary. He is one of the main contributors to creating and organizing the society’s annual BAPHCON conference in Bahrain, now serving as a podium for pharmacists in the GCC region to share their knowledge and experiences"

Dr. Ali Saleh Al Younis

Clinical Pharmacist in Internal Medicine at King Faisal General Hospital, Al-Ahsa | Saudi Arabia

Dr. Ali Saleh Al Younis obtained his Doctor of Pharmacy degree in 2013 and completed his PGY-1 Pharmacy Residency in 2021, followed by a PGY-2 in Internal Medicine at King Khalid Medical City. He currently serves as a Clinical Pharmacist in Internal Medicine at King Faisal General Hospital, Al-Ahsa. Dr. Al Younis is a Board-Certified Pharmacotherapy Specialist (BCPS) with a strong focus on antimicrobial stewardship, therapeutic drug monitoring, and evidence-based clinical practice. He has served as a speaker and moderator in multiple national scientific conferences and is dedicated to advancing clinical pharmacy practice, research, and education across Saudi Arabia.

Dr. Amna Almuaini

BPharm, Master of Clinical Pharmacy,BCPS, | United Arab Emirates

Dr. Amna Ibrahim Ahmed Almuaini is a Board-Certified Pharmacotherapy Specialist (BCPS) and Clinical Pharmacist with over 14 years of progressive experience in hospital pharmacy, specializing in cardiology and clinical project leadership. She currently leads cardiology clinical pharmacy services at Tawam Hospital in Al Ain, UAE, where she oversees medication safety, therapeutic optimization, and multidisciplinary collaboration to enhance patient outcomes. Dr. Almuaini holds a Master of Clinical Pharmacy from Dubai Pharmacy College and has completed advanced leadership training through the Royal College of Surgeons in Ireland. She is recognized for her strategic leadership in healthcare initiatives, including leading a SEHA-wide project that significantly reduced near-expiry medication waste across more than ten hospitals, improving cost efficiency and regulatory compliance. An active leader in the profession, Dr. Almuaini serves on the Board of the Emirates Pharmacy Society and the ISPOR UAE Chapter. She has presented and published at major international conferences such as the ASHP Midyear and the Middle East Heart Failure Conference, reflecting her commitment to advancing clinical pharmacy practice and innovation. With expertise spanning clinical governance, team development, and strategic planning, Dr. Almuaini is passionate about driving excellence in pharmaceutical care and shaping the future of pharmacy through leadership, research, and education.

Dr. Amr Saad

BSc. Pharm, MSc, PhD. CEO, VigiHub consultancy agency Former WHO pharmacovigilance consultant Former Associate Minister of Health for Pharmaceutical Affairs Senior Clinical Lecturer in severa | United Arab Emirates

"Dr. Amr Saad is a globally recognized expert in pharmacovigilance, regulatory affairs, and strategic health governance, with over 26 years of leadership across Egypt and the Arab region. He holds a PhD in Epidemiology from the University of Manchester and has participated in over 260 national and international conferences, publishing extensively in PubMed-indexed journals. As the founding head of the Egyptian Pharmaceutical Vigilance Center (EPVC), Dr. Saad built Egypt’s national PV infrastructure from the ground up—establishing SOPs, ADR databases, WHO-UMC integration, and a nationwide yellow card system. He led national PV audits to evaluate system integrity, regulatory compliance, and risk-based performance across MAHs and healthcare institutions. He also spearheaded awareness campaigns, curriculum integration across 12 universities, and regulatory mandates requiring PV departments in all MAHs. Dr. Saad served among the main consultants for the establishment of the Egyptian Drug Authority (EDA), leading the adoption of CTD/eCTD, pricing reforms, and drafting Egypt’s Strategic Health Map 2030. As Associate Minister of Health, he oversaw pharmaceutical sector reform, essential medicines lists, SSFFC countermeasures, and crisis management protocols. Regionally, he chaired the Arab League’s Higher Technical Committee for Medicines, authoring the Common Arab Guidelines for Pharmacovigilance and Bioequivalence, approved by Arab Ministers of Health. His harmonization efforts shaped cross-border regulatory alignment and institutional capacity-building. Dr. Saad also serves as a strategic consultant to multinational pharmaceutical companies, providing expert guidance to strengthen and optimize their pharmacovigilance infrastructures. He is the Founder and CEO of VigiHub® Consultancy and Training Agency, delivering over 460 workshops and training 15,000+ professionals across 20+ countries in PV, pharmacoepidemiology, and regulatory systems. His academic leadership spans multiple Egyptian universities, where he developed Pharm D, MSc, and PhD programs, PV diplomas (Cairo & Sharjah), and supervised over 15 postgraduate theses. Dr. Saad is a WHO consultant focused on integrating PV functions at hospital levels and launching nationwide TOT campaigns. He serves on national ethics boards, clinical pharmacy fellowship committees (MOH & Military), and the ruling board of CRC-TBRI. His contributions to herbal clinical trial guidelines, curriculum evaluation, and regulatory audits position him as a strategic force in global drug safety and regulatory science"

Dr. Anas Hamad

Director of Pharmacy Department at Qatar's National Center for Cancer Care & Research. He is the Head of Medication Safety & Quality Center and Head of Pharmacy Research Center at Hamad Medi | Qatar

Dr. Anas is currently the Director of Pharmacy Department at Qatar's National Center for Cancer Care & Research. He is the Head of Medication Safety & Quality Center and Head of Pharmacy Research Center at Hamad Medical Corporation's Pharmacy Executive Office. He holds a position at Qatar University as a Clinical Associate Professor of Clinical Pharmacy & Practice. He is chairing the Standing Committee on Medication Services at Qatar Red Crescent Society. He is also the Vice President & Director of ISPOR Qatar Chapter. In addition, he is leading the Health Technology Assessment and Innovation Regulation Project under the National Health Strategy in the Ministry of Public Health. Dr. Anas finished his BSc in Pharmacy at the University of Jordan. He obtained MSc in Clinical Pharmacy, International Practice & Policy from the University of London and PhD in Clinical Practice & Medication Use from King's College London. He also acquired an Executive Diploma in Health Services Management from GSM London. Furthermore, he completed the Executive Leaders Program with Qatar Leadership Centre. That is in addition to multiple postgraduate certificates in health technology assessment, supply chain management, human subjects research, quality management, health economics and outcomes research. Dr. Anas is an active researcher with several publications and conference proceedings. He is an Editorial Board Member at International Journal of Clinical Pharmacy and Review Editor at Frontiers in Oncology. He regularly speaks at local and international conferences. He is a member of both HMC's and QU's Institutional Review Boards in addition to the MOPH National Clinical Research Review Committee. Moreover, he is a member of various committees/boards focusing on pharmacy practice, medication use, cancer care, research, safety & quality, medical affairs, healthcare education, health economics, governmental tenders, clinical transformation, and health insurance"

Dr. Aqila Mohammed Hassan Taqi

Consultant pharmacist at Sultan Qaboos University Hospital- pharmacy department | Oman

Dr. Aqila Mohammed Hassan Taqi is a consultant pharmacist at Sultan Qaboos University Hospital- pharmacy department. She has over 15 years’ experience in clinical pharmacy practice, as a clinical pharmacist for paediatrics and bone marrow transplantation services and more recently in neonatal and paediatric critical care services. Aqila was also the pharmacy’s quality representative since 2010 and coordinated the department’s accreditation preparedness activities for both ISO 9001 certification and later on for Accreditation Canada International (ACI) certification at SQUH . Dr. Aqila pursued her PhD in pharmacoepidemiology and clinical pharmacy from the University of Nottingham –UK in July 2020. Her research was on analgesics’ safety in primary care patients in UK, for which she used data from the clinical practice research datalink, one of world’s largest medical records databases. Upon her return, she was honoured by Oman’s first lady her highness Sayedah Ahd Bint Abdulla on the country’s women’s day for her contribution to the nation’s progress She has special interest in clinical pharmacy practice and safe use of medications and her work was published in a number of peer reviewed scientific journals."

Dr. Ashraf Elhoufy

Consultant | United Arab Emirates

Graduate of Alexandria Faculty of Medicine (Nov. 1984), with honour. Master Degree in Chest Diseases with Critical care sub-specialty 1989 MRCP (UK) November 1997 and awarded FRCP (London) 2008. European Diploma of Intensive Care Medicine (EDIC) 2012. Currently, Consultant / Head ICU Al Zahra Hospital Dubai. Examiner for the Royal College of Physician (UK), Professor of Medicine Dubai Medical College, Vice president of the Emirates Intensive Care Society (EICS),

Dr. Baref Zahir Rashid

Assistant Professor of Pharmacology - Head of Syndicate of Kurdistan Pharmacists-Iraq (SKPI) | Iraq

President, Kurdistan Pharmacy Summit – Erbil (2021) • President, Iraq/Kurdistan Pharmacy Summit – Sulaimaniyah (2022) • President, First National Conference on Combating Microbial Resistance Against Antibiotics and Development of Pharmacovigilance in the Kurdistan Region (2023). • President, Pharmacist summit (2024). • President, PharmaDev Conference (2025) , Lecturer, Pharmacy Department, Sulaimani Technical Institute, Sulaimani Polytechnic University (September 2009 – March 2010) • Head of Pharmacy Department, Sulaimani Polytechnic University (March 2011 – September 2021) • Assistant Professor of Pharmacology (2025 – Present) • Member, Kurdistan Higher Council for Medical Specialties (KHCMS) (2024 – Present)"

Dr. Barry A. Bleidt

Barry A. Bleidt, PhD, PharmD, RPh, FAPhA Adjunct Professor, Economic, Social, & Administrative Pharmacy Division College of Pharmacy and Pharmaceutical Sciences | Institute of Public Health | USA

Adjunct Professor, Economic, Social, & Administrative Pharmacy (ESAP) Division College of Pharmacy and Pharmaceutical Sciences | Institute of Public Health at Florida A&M University. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has over forty years of professional experience in preventing drug use problems and substance misuse, looking at quality and advanced Pharmacy services, and looking towards the future of the profession. Dr. Bleidt served six years as Chair of the Program Committee for the Pharmacy Section of the American Public Health Association and fourteen years for the Alcohol, Tobacco, and Other Drugs Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the United States Pharmacopoeia Convention from 1985 to 2020. Dr. Bleidt has also serves as the CEO of the Practicing Pharmacists Institute, Inc., an ACPE-accredited organization He has developed and administered Advanced Practice Certificate Programs and has been involved with the Immunization Certification Training of over 1,500 pharmacists, pharmacy technicians, and student pharmacists. Dr. Bleidt is the current Deputy Editor of the Elsevier Journal, Currents is Pharmacy Teaching and Learning. He delivered over 400 presentations and has been the Keynote Speaker at several International Conferences, including the Risk Behavior Research in International Settings Conference and DUPHAT. He published over fifty articles and book chapters. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt received the Lifetime Achievement Award from the Pharmacy Section of the American Public Health Association. (2021) He was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001); and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida."

Dr. Basem Abu Baker

Phd, | Jordan

Dr. Basem is an internationally trained nutrition and healthcare leader with dual PhDs in Nutrition and Health Care Administration (UK) and Community Health (USA), a Master’s degree in Nutrition from San José State University, and a Bachelor’s degree from the University of Jordan. He holds multiple international certifications, including Board Certified Diabetes Educator (USA), Certified Nutrition Support Dietitian (USA), Registered Nutritionist (UK), and certifications in quality management, food safety, and strategic leadership from the UK and Germany. Dr. Basem has held senior leadership roles across the Middle East, including Head of the Healthy Eating Advisory Program at Johns Hopkins Aramco Healthcare and Head of Nutrition and Diabetes Education Committee of the Saudi Diabetes and Endocrine Association. He has also served as Nutrition Advisor to major health foundations in Saudi Arabia and as a consultant to leading healthcare institutions in Jordan. A prolific author, speaker, and program developer, he has led numerous accredited training initiatives, developed national nutrition and elder-care programs, and received multiple awards from governmental and professional organizations in Saudi Arabia and Jordan for his contributions to healthcare, nutrition, and community outreach.

Dr. Carole Wehbe Chidiac

M.D,Consultant Family Medicine,Eating Disorders Specialist,Occupational Medicine,Sports and Exercise Medicine. | United Arab Emirates

Dr Carole Wehbe Chidiac is a Family Medicine Consultant specialized as well in Eating Disorders, Sports and Exercise Medicine and occupational medicine. She is accredited in cognitive behavioral therapy for eating disorders and trained in other psychological approaches to lifestyle changes. She has been practicing for almost 30 years and her approach is evidence based, holistic, non judgmental and collaborative, based on informed decisions. Dr Carole is an author and a speaker focusing mainly on educating health care professionals about the negative consequences of weight stigma and weight cycling, and the benefits of a weight inclusive approach to health and wellbeing. She participated as an instructor and supervisor in many workshops and trainings including the CBTE training of the first eating disorder unit at AUB-MC.

Dr. Cyrine-Eliana Haidar

Associate Member at St. Jude Children’s Research Hospital, where she also serves as the Clinical Pharmacogenomics Residency Program Coordinator in the Department of Pharmacy and Pharmaceutica | USA

Dr. Cyrine-Eliana Haidar is an Associate Member at St. Jude Children’s Research Hospital, where she also serves as the Clinical Pharmacogenomics Residency Program Coordinator in the Department of Pharmacy and Pharmaceutical Sciences. With over two decades of experience in clinical pharmacy and pharmacogenomics, Dr. Haidar is a nationally and internationally recognized leader in the implementation of precision medicine in pediatric oncology. She earned her Doctor of Pharmacy degree from the Lebanese American University and completed postgraduate residencies in Pharmacotherapy at Hackensack University Medical Center and Pediatric Oncology at St. Jude Children’s Research Hospital. Her career at St. Jude began in 2005, where she initially served as the Clinical Pharmacy Specialist taking care of patients with solid tumors and brain tumors. In 2012, her role transitioned to a Coordinator of Clinical Pharmacogenetics, and then as a Senior Program Manager for Clinical Pharmacogenomics. Dr. Haidar is board certified by the Board of Pharmacy Specialties (BPS) in both pharmacotherapy and oncology pharmacy and is a Fellow of the American Society of Health-System Pharmacists (ASHP). She has played a pivotal role in the development and expansion of the PG4KDS protocol, a landmark initiative for preemptive pharmacogenetic testing at St. Jude. Her leadership extends to national and global platforms, including serving as Chair of the BPS Board of Directors, co-chair of the Epic Pharmacogenomics Brain Trust, and she is a Board member of the Epic Genetic and Genomics Specialty Steering Board. She has authored over 50 peer-reviewed publications and contributed to numerous clinical guidelines through the Clinical Pharmacogenetics Implementation Consortium (CPIC). Her work has been recognized with multiple awards, including the ACCP Clinical Practice Award and two ASHP Foundation Pharmacy Literature Awards for Innovation in Pharmacy Practice. Dr. Haidar is also deeply committed to education and mentorship, having trained numerous pharmacy students, residents, and fellows. Her efforts have helped shape the next generation of pharmacists and pharmacogenomics practitioners. "

Dr. Dominik Thor

President & Professor of Pharmacy Geneva College of Longevity Science | Switzerland

Dominik Thor is the President of the Geneva College of Longevity Science (GCLS), the world’s first higher education institution dedicated exclusively to the study of longevity science. A leading authority in longevity education and an internationally recognized speaker on longevity innovation, technology, and policy, he is at the forefront of shaping the academic and strategic future of this emerging discipline. He serves as Chair of the GCLS Semester Symposium, a leading international conference connecting experts and institutions from Europe, Asia, and the GCC, and as Co-Chair of several scientific events focused on advancing the standards and practice of longevity medicine worldwide. In his academic capacity, Dominik oversees the medical and executive education programs at GCLS and serves as Professor of Pharmacy. He is also a Visiting Professor at the University of Medicine and Pharmacy “Carol Davila” (UMFCD), contributing to the advancement of Gerontology, Geriatrics, and Longevity Medicine. An active contributor to the academic discourse, Dominik writes scientific articles on longevity education, policy, and innovation. With a research background in biomaterials, regenerative medicine, and pharmaceutical sciences, he has authored numerous peer-reviewed publications and holds multiple patents in Europe and the United States related to cell regeneration and aesthetic science.

Dr. Ehsan Habeeb

Cardiology Consultant Clinical Pharmacist Taibah University – College of Pharmacy | Saudi Arabia

"Dr. Ehsan Habeeb is a Cardiology Consultant Clinical Pharmacist and Assistant Professor at Taibah University – College of Pharmacy, where he also serves as the Director of the Alumni Center and the Head of the Pharmacy Practice Department. He completed his Post‑Graduate Year 1 (PGY1) Pharmacy Residency and Post‑Graduate Year 2 (PGY2) Cardiology Residency at Massachusetts General Brigham, a Harvard Medical School–affiliated institution in Boston, United States. He further advanced his expertise through a Fellowship in Cardiology Pharmacotherapy and Clinical Research at the same institution. Dr. Habeeb is Board Certified Pharmacotherapy Specialist (BCPS), a Board Certified Cardiology Pharmacist (BCCP), and a Certified Anticoagulation Care Provider (CACP). With a strong foundation in cardiovascular pharmacotherapy, Dr. Habeeb is recognized for his contributions to clinical practice, patient safety, and guideline-driven care. His clinical expertise spans heart failure, arrhythmias, anticoagulation, and complex cardiovascular pharmacotherapy—supporting evidence-based decision‑making in both acute and chronic care settings. He has authored and co‑authored numerous peer‑reviewed publications in international journals and actively supervises several clinical and academic research projects in cardiology, anticoagulation, and medication‑related outcomes. As Head of the Pharmacy Practice Department at Taibah University, Dr. Habeeb has led several initiatives aimed at elevating the quality of pharmacy education and advancing clinical pharmacy practice. His efforts include curriculum enhancement to align with global accreditation standards, expansion of experiential training sites, development of structured clinical rotations, and the integration of research and simulation‑based learning into student training. He works closely with local healthcare institutions to strengthen hospital–university collaborations, support pharmacist workforce development, and enhance patient-centered care models across the region. Through his extensive clinical experience, academic leadership, and continuous pursuit of innovation in pharmacy practice, Dr. Habeeb plays a pivotal role in advancing clinical pharmacy and cardiovascular care both in Saudi Arabia and across the Middle East. His collaborative efforts with clinical pharmacists from various Gulf countries and healthcare institutions have contributed to the development of regionally-relevant practices, training standards, and research initiatives aimed at elevating the quality of pharmaceutical care."

Dr. Eiman Al Hinai

Ph.D, Head of the Clinical Nutrition and Dietetics Department | Oman

She is the Head of the Clinical Nutrition and Dietetics Department at the Directorate General of Khoula Hospital. She holds a Ph.D. in Clinical Nutrition and Dietetics from the University of Reading, United Kingdom. Beyond her leadership role at Khoula Hospital, Dr. Eiman serves as a member of the Evaluation Committee at the Consumer Protection Authority and is the President of the Omani Nutrition and Dietetics Society. She is also an active member of numerous national professional and governmental committees, where she plays a key role in shaping nutrition-related policies and regulations. With more than 20 years of experience in clinical nutrition, Dr. Eiman is a highly respected expert in her field. She has been a keynote speaker at many national and international conferences and has delivered academic lectures at the Oman College of Health Sciences. Her work extends to extensive collaboration with institutions both within the Sultanate of Oman and internationally. Dr. Eiman has organized, led, and chaired several international conferences, workshops, and scientific symposiums in clinical nutrition. She has been instrumental in the development of enteral and parenteral nutrition protocols, as well as hospital policies, clinical guidelines, and standard operating procedures that support safe, evidence-based patient care. Her academic contributions include the publication of multiple scientific papers in high-impact, peer-reviewed journals. In parallel with her academic and leadership roles, Dr. Eiman has provided nutritional counselling to thousands of patients over the past two decades, supporting the management of disease-specific nutritional needs, sustainable weight loss, and other chronic conditions. Through personalized, evidence-based nutrition programs, she has significantly improved patient outcomes and quality of life.

Dr. Emad Alsarraf

Assistant professor in pharmacy practice department at Kuwait University Part-time practices as clinical pharmacist at the emergency department in Mubarrak Alkabeer | Kuwait

Currently lectures as assistant professor in pharmacy practice department at Kuwait University Part-time practices as clinical pharmacist at the emergency department in Mubarrak Alkabeer, Kuwait In 2017, graduated with pharmD from MCPHS university, Worcester, USA After which, completed PGY1 residency, PGY2 in emergency medicine, and 2-years of clinical fellowship in Brigham and Women’s Hospital, Boston, USA Currently board-certified specialist in in pharmacotherapy (BCPS) and emergency medicine (BCEMP) Favorite drug: Epinephrine

Dr. Fakher Alayobi

B. Pharm, MSC, Rph, BHF, MBA, ABSP, PhD | Saudi Arabia

• Intensivist Cardiology Clinical Pharmacist, Head of the Cardiology Quality Pharmacy Team, department of cardiac sciences King Fahed Cardiac Center (KFCC), College of Medicine. • Adjunct Assistant Professor, College of Pharmacy, at King Saud University. • The founder and first President, of Cardio Clinical Pharmacy Group, at Saudi Heart Association • The founder of women chapter at the Saudi Pharmacy Society • Establishing as well as implementing different national guidelines, with the collaboration of MENA and Global Countries. • Lead the world’s largest international health care practitioners & health technology gathering in the pandemic era under the name of SCOPE. Dr Fakhr has a PhD & master’s degree in clinical pharmacy research as well as master’s in business administration. She is Board certified in clinical poisoning management, Heart Failure, and specialized Arab Board in Cardiology Pharmacy. Dr Alayoubi, is certified as train the trainer for metabolic syndrome (Diabetes, Cardiovascular Disease) from the American Pharmacy Association APhA, Meddle East Representative (EMRO) for the Europe pharmacy society FIP (Foundation of International Pharmacy) for Hospital pharmacy and the leader for the global anticoagulation stewardship research, finally the founder and primary investigator of the Saudi Amyloidosis registry (SAMR).

Prof. Farah Naja

Professor | United Arab Emirates

Professor Farah Naja is a Professor of Nutrition and Dietetics at the Department of Nutrition and Dietetics at the University of Sharjah. She is an internationally recognized nutrition epidemiologist whose research focuses on the role of diet and lifestyle in the prevention and management of non-communicable diseases (NCDs). Her recent work has increasingly explored the integration of complementary and alternative medicine (CAM) into evidence-based public health and clinical nutrition. Professor Naja leads several multidisciplinary research projects examining the prevalence, determinants, and health impacts of CAM use in Middle Eastern populations, particularly in the context of chronic disease management and women’s health. Her publications have contributed to shaping the understanding of how traditional healing practices, herbal medicine, and dietary supplements intersect with conventional healthcare systems. Recipient of the Abdul Hameed Shoman Award for Best Arab Researcher (2023), Professor Naja has authored over 160 peer-reviewed publications and led the first regional cohort study on nutrition and lifestyle in the Middle East (MINA), in Beirut and Doha. Through her research and advocacy, she promotes culturally sensitive, integrative approaches that bridge scientific rigor with traditional health practices.

Ms. Farheen Dhinda

Clinical Dietitian-Clinical Nutrition Department, Dubai Health | United Arab Emirates

Clinical Dietitian-Clinical Nutrition Department, Dubai Health

Dr. Fathea Adheir

Director of Pharmacy at Sidra Medicine | Qatar

Fathea Adheir is the Director of Pharmacy at Sidra Medicine in Doha, Qatar, with over 23 years of experience in hospital pharmacy and healthcare leadership. She holds a pharmacy degree and an Executive MBA from HEC Paris–Qatar. Ms. Adheir is recognized for her commitment to quality, patient safety, and innovation in pharmacy practice. Throughout her career, Ms. Adheir has led the implementation of advanced pharmacy automation systems and played a pivotal role in activating and managing comprehensive pharmacy services at Sidra Medicine. Her leadership has contributed to the successful launch of multiple hospital pharmacy services, and she has been instrumental in developing medication management policies and optimizing inventory processes. Ms.. Adheir is a strong advocate for patient-centered care and believes in the importance of involving patients in their treatment journey. She is also active in public health education, using social media to raise awareness about medication safety and proper usage. Her influence extends beyond Sidra, as she is a member of the MENA coalition for HPV elimination and collaborates with WHO groups on regional strategies for cervical cancer screening and prevention. Her dedication to excellence has been recognized with awards such as the Stars of Excellence from Hamad Medical Corporation for quality and patient safety. Ms. Adheir continues to contribute to the advancement of pharmacy practice through research, education, and active participation in regional and international conferences."

Dr. Fatima Alraisi

President of Oman pharmaceutical society board Associate professor at Oman College of Health Sciences" | Oman

A distinguished clinical pharmacist, academic leader, and President of the Oman Pharmaceutical Society (OMPHS) with over 24 years of experience in nephrology pharmacotherapy, clinical pharmacy, and higher education. With a Ph.D. in Clinical Pharmacy and a strong background in leadership, stakeholder engagement, and strategic partnerships, I am committed to advancing the pharmacy profession by integrating education, research, and policy advocacy. As President of OMPHS, I have successfully led national and international collaborations with GCC pharmaceutical societies, global pharmaceutical companies, and medical and non-medical organizations in Oman. My efforts have resulted in fundraising initiatives, policy advancements, and educational collaborations that enhance pharmacy practice and public health in Oman. My strategic vision drives continuous improvement in pharmacy education, pharmaceutical regulations, and clinical practice, ensuring excellence in patient care, research, and professional development. I’m well recognized for building strategic alliances, policy advocacy, and high-impact negotiations to strengthen healthcare education and clinical practice. A strong communicator and influencer, serving as a key representative in international conferences and advisory panels which foster experience in external relations, stakeholder engagement, strategic partnerships, build high-level"

Dr. Ghada Bawazeer

MSc, PharmD, BCPS, BCMTMS, PgDipl (Diabetes),Associate Professor of Clinical Pharmacy | Ambulatory Care Consultant Clinical Pharmacist | Saudi Arabia

Clinician-educator specializing in ambulatory care, curriculum development, experiential education, and evidence-based practice. Board-certified in pharmacotherapy and medication therapy management with extensive clinical practice in diabetes, MTM, geriatrics, and anticoagulation clinics, and committed to guideline-informed practice, high-quality teaching, and community health impact. "

Dr. Huda Alharthi

Consultant pharmacist with over 20 years’ experience in clinical pharmacy practice | Oman

With a rich career spanning 22 years at Khoula Hospital, Muscat, Oman, Huda Al Harthy is a consultant pharmacist with over 20 years’ experience in clinical pharmacy practice. She hold MSc degree in Clinical pharmacy from Strathclyde University/ UK. She worked as head of clinical pharmacy for 17 years and acting director of pharmacy directorate in Khoula Hospital She practiced clinical pharmacy in various surgical specialties such as orthopedics and general surgery. She has been an integral member of the hospital’s Drug Therapeutic Committee, addressing complex medication-related issues and contributing to hospital-wide audits, training, and educational initiatives. Huda also being involved in developing different guidelines, policies and procedures; for example standards of clinical pharmacy practice (which highlight on the important skills needed in clinical pharmacy, these SOP being approved by the hospital quality department), OPAT service, osteoporosis national guideline and national antimicrobial management guideline. In addition to her committee roles, she has actively participated in numerous pharmaceutical events both locally and internationally, often serving as a speaker or poster presenter. Her passion for pharmacotherapy improvement and her extensive experience in clinical education have made her a respected mentor and a driving force in the continuous improvement of pharmacy practice. She has recently transitioned into Drug Safety Center, bringing her clinical pharmacy expertise into the realm of medication registration and regulatory affairs. Furthermore, she is member of Taskforce of the Central Drug Committee in Ministry of Health. "

Prof. Hussain Bakhsh

Professor of Pharmacy Practice, Consultant clinical pharmacist, Director of Pharmaceutical Services at King Abdulaziz University Hospital. " | Saudi Arabia

Prof. Hussain Bakhsh is the director of the pharmaceutical services and professor of pharmacy practice at The Faculty of Pharmacy, King Abdulaziz University. Prof. Bakhsh earned his Doctor of Pharmacy degree from King Abdulaziz University after which time he completed Pharmacy Practice Residency and Emergency Medicine Specialty Residency training at The University of Arizona. Dr. Bakhsh’s area of research includes: Emergency medicine, pharmacy practice, and pharmacy education

Prof. Hussien Heshmat Ali Kassem

Consultant interventional cardiology, | United Arab Emirates

Dr. Hussien Hishmat is a Professor of Cardiology at Cairo University, holding fellowships with the American College of Cardiology, European Society of Cardiology, and the Society of Cardiac Angiography and Interventions. He serves as a consultant interventional cardiologist in the UAE, with extensive experience in over 6000 interventional procedures. Dr. Heshmat's expertise lies in cardiovascular prevention, complex coronary interventions, peripheral vascular interventions, valvular interventions, and heart failure management. He has been recognized with four awards in interventional cardiology in Egypt and the UAE, and has contributed 50 international publications with 1000 citations. Currently, Dr. Heshmat also serves as the associate editor of the Egyptian Heart Journal.

Dr. Jagmeet Madan

MSc .MPhil. PhD ( Food and Nutrition) | India

Professor (Dr.) Jagmeet Madan is an eminent clinical nutritionist with over 30 years of experience in academia, research, and national health policy. She serves as President of the Nutrition Science Professional Council under the National Commission for Allied and Healthcare Professions (NCAHP), Ministry of Health and Family Welfare, Government of India (2025). She is Professor, Director of Postgraduate Programs and Research, Innovation, Collaboration and Consultancy Centre (RICCC), and former Principal (2009–2024) of Sir Vithaldas Thackersey College of Home Science, SNDT Women’s University, Mumbai. A former National President of the Indian Dietetic Association, she has contributed extensively to national policy as a member of key task forces and as an expert with FSSAI scientific panels. She represents India at the Asian Federation of Dietetic Associations (AFDA) and the International Confederation of Dietetic Associations (ICDA). A gold medalist with over 60 peer-reviewed publications, she is the recipient of the Young Scientist Award and Dr. Ramanathan Award from the Nutrition Society of India. She holds MSc, MPhil, and PhD degrees in Food and Nutrition and is a Certified Diabetes Educator (IDF) and Certified FODMAP Nutritionist (Monash University).

Dr. Janak Nathan

Consultant Neurologist | India

Dr. Janak Nathan is a Consultant Neurologist at Shushrusha Citizens Co-operative Hospital, Mumbai, and a pioneer of ketogenic dietary therapy in Asia. A member of the ILAE Task Force for Dietary Therapies, he has advanced the use of ketogenic interventions for epilepsy, cancer, and neurodegenerative disorders including Alzheimer’s disease, autism, and multiple sclerosis. He founded the Vijay Epilepsy Care Foundation in 1996 to promote epilepsy awareness and ketogenic diet access across India, including rural outreach programs. Dr. Nathan serves on the executive committees of the International Neuro Ketogenic Society (INKS) and the Global Society of Metabolic Therapy and has published extensively in international journals. In 2023, he became the first Asian recipient of the prestigious Dr. John Freeman Award at the Global Ketogenic Therapies Symposium in San Diego.

Dr. Juan Camilo Cortes

Director, Division of Neurorehabilitation | United Arab Emirates

Dr. Juan Camilo Cortés is a consultant vascular neurologist and Medical Director of the Dubai Physiotherapy and Rehabilitation Center and Chair of the Division of Neurorehabilitation at Dubai Health, as well as a researcher at the Lake Lucerne Institute. He completed a postdoctoral training at Columbia University in New York and trained in neurology at Johns Hopkins then completed a vascular neurology fellowship at the University of Cincinnati. With over a decade of research in neuroscience, he now leads a system-wide modernization of public neurorehabilitation services across Dubai

Dr. Khaled M.EL-Atawi

• MB.B.Ch., M.Sc. & PhD. | Egypt

• Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, EGYPT • Master Healthcare Management, Royal College of Surgeon of Ireland. • A/Consultant Neonatology, NICU, Latifa Hospital • Clinical Quality Specialist, Latifa Hospital • Lecturer of Pediatrics in Dubai Medical College • Pediatric Resident Supervisor, Latifa Hospital DHA • Regional Trainer for NRP by AAP since 2014 • STABLE Course director in Latifa Hospital • Editorial Board member of the journal “Pediatric and neonatal nursing” • Editorial Board member of Journal of Pediatrics & Neonatal Care. • President of Arab Neonatal Group and Congress • International Member in American Academy in Pediatrics. • Board member of Pediatric Arab Union. • Member in the Scientific Board of the International Academy of Neonatology. • Field of interest Neonatal Ventilation, Neonatal Nutrition, Brain injury and protection. • Working with team on quality improvement projects with positive results especially on reducing incidence of severe IVH and ROP as well.

Dr. Lara Nasreddine

PhD, LD, Professor (Human Nutrition). | Lebanon

Dr. Lara Nasreddine is a Professor of Nutrition at the American University of Beirut, Lebanon, where she also serves as Associate Dean for Academic and Student Affairs and as Co-Chair of the Institutional Review Board. Her research interests focus on dietary assessment and the investigation of diet as a determinant of obesity and cardiometabolic health. She has authored over 150 peer-reviewed manuscripts in international journals and several book chapters. Over the past decade, she has established a record of professional service to the WHO, FAO, and UNICEF, including serving on UNICEF’s Technical Advisory Group on School-Age Children and Adolescent Nutrition Metrics. She won the Abdul Hameed Shoman Award for Arab Researchers, is an elected Associate Fellow at the Académie d’Agriculture de France and received the AUB Board Designated Professorship Award.

Dr. Maria J. Alonso

Professor of Pharmacy and Pharmaceutical Technology | Spain

Chair of Nanomedicine and Drug Delivery Lab, USC Editor-in-Chief of the Drug Delivery and Translational Research (DDTR) Journal Former President of the Controlled Release Society (CRS)"

Dr. Maryam AlObaidly

PharmD., MSc., BCPS, FQS Assistant Professor at the Department of Pharmacy Practice | Kuwait

Maryam AlObaidly embarked on a transformative academic and personal journey at a young age when she left her home in Kuwait to pursue education in Ireland. As a determined and ambitious high school student entering a new educational system, she embraced a foreign culture while navigating the challenges of independence. This exciting yet demanding transition shaped her resilience and sparked a passion for pharmacy that continued to grow throughout her studies. During her early years in the Pharmacy Program at the Royal College of Surgeons in Ireland (RCSI), Dr. AlObaidly cultivated a deep appreciation for patient-centered care and the science underlying medication therapy. By her second year, her interest in pharmacology evolved from curiosity into purpose. She completed her Bachelor of Pharmacy (BPharm) degree and was selected to join a competitive Master’s research program focused on platelet activation during pregnancy, which strengthened her commitment to evidence-based clinical practice and interprofessional collaboration. Upon returning to Kuwait, she began her professional career in a variety of clinical and hospital settings. Her diligence, communication skills, and passion for mentorship quickly earned the trust of directors and clinical leaders, who encouraged her involvement in training junior pharmacists and technicians. As the healthcare landscape in Kuwait advanced toward a more clinically integrated pharmacy practice, the transition to the Doctor of Pharmacy (PharmD) curriculum at Kuwait University motivated her to pursue further education and align her capabilities with the evolving needs of the profession. She was accepted into the PharmD program at MCPHS University, an institution recognized for its strong academic networks and clinical connections with Harvard-affiliated hospitals. Throughout her advanced practice experiences, particularly in internal medicine and critical care, she refined her ability to manage complex pharmacotherapy and actively contribute to clinical decision-making. Her leadership, professional service, and commitment to advancing pharmacy were acknowledged through her induction into Phi Lambda Sigma, the Pharmacy Leadership Society, a recognition granted to outstanding leaders who demonstrate dedication to the profession. Driven by her passion for improving patient safety and optimizing therapeutic outcomes, Dr. AlObaidly completed a prestigious fellowship in the Department of Quality and Safety at Brigham and Women’s Hospital, one of Harvard Medical School’s major teaching hospitals. Her work focused on critical aspects of healthcare delivery, including medication reconciliation, pain management practices, and improving vaccination rates among vulnerable populations, while also collaborating with interdisciplinary teams on heart failure and home care initiatives. During her first year of postgraduate residency training (PGY1), she also completed the Teaching and Learning Certificate (TLS) through Northeastern University in Boston, further strengthening her pedagogical skills and commitment to pharmacy education. Her desire to expand her clinical expertise further led her to pursue a two-year subspecialty residency in Solid Organ Transplantation (PGY2) at the same institution, after which she earned Board Certification in Pharmacotherapy (BCPS). With this wealth of international training, she returned to Kuwait as a Clinical Pharmacy Specialist in the Bone Marrow Transplant unit at the Cancer Control Center. In parallel, she accepted a faculty position as an Assistant Professor at Kuwait University, where she is deeply committed to preparing future pharmacists through teaching, clinical instruction, and research mentorship. She continues to elevate pharmacy practice nationally through professional development initiatives for Ministry of Health pharmacists, including leading Medication Therapy Management (MTM) performance evaluations, delivering a Board of Specialized Pharmacy review sessions in collaboration with KUPHA, and presenting advanced Therapeutic Drug Monitoring education and evaluations to enhance clinical pharmacy capabilities across the healthcare system. In October 2025, Dr. AlObaidly’s excellence in academic mentorship and her dedication to shaping the next generation of pharmacists were recognized with the Inspiring Educator Award from RCSI’s School of Pharmacy and Biomolecular Sciences. Her journey from a young Kuwaiti student discovering her passion abroad, to a respected clinician, faculty member, and mentor reflects an unwavering devotion to advancing patient care, empowering healthcare professionals, and enriching the future of pharmacy through leadership, innovation, and lifelong learning.

Dr. Mohamad Miqdady

MD, American Board of Ped. GI Chief, Ped. GI, SKMC, UAE Clinical Professor | United Arab Emirates

 American Board certified in Pediatric Gastroenterology  Division Chief, Pediatric Gastroenterology at Sheikh Khalifa Medical City in UAE.  Clinical Professor, Khalifa University, UAE.  Established Pediatric Liver transplant program. March 2025

Prof. Mohamed Baraka

Professor of Clinical Pharmacy & Former Dean of Pharmacy, FCHS , UAE. AI & Digital Health Expert. CEO, Intelligent Horizons | Saudi Arabia

"Dr. Mohamed Baraka is an internationally recognized academic leader and digital health innovator dedicated to advancing the integration of technology across healthcare and medical education. With over two decades of academic, clinical, and leadership experience across Egypt, Saudi Arabia, Belgium, and the United Arab Emirates, Dr. Baraka has been instrumental in driving digital transformation within the health sciences sector. As Associate Professor and Former Dean of Pharmacy at Fatima College of Health Sciences (FCHS), Dr. Baraka spearheaded the successful national (CAA) and international (ACPE) accreditation of the pharmacy program while embedding digital health, telehealth, AI literacy, and automation concepts into the health sciences curriculum. His initiatives have fostered interprofessional collaboration and future-ready competencies among medical, nursing, and allied health students. Globally, Dr. Baraka serves as Co-Lead of the Programme Development Working Group in the International Pharmaceutical Federation (FIP) Academic Pharmacy Section, contributing to the development of digital health and AI education programs for healthcare educators and professionals worldwide. He is also the Global AI Delegate to the UAE at the Global Alliance for Artificial Intelligence (GAFAI) and the chair of the industry cooperation & collaboration working group of GAFAI. In addition, he is an active member of the HealthAI Community of Practice, where he contributes to the evaluation and validation of AI in health and responsible AI governance frameworks. His leadership extends to the UAE National Taskforce for Interprofessional Education Framework for Healthcare Practitioners, helping shape collaborative practice standards for the country’s health education ecosystem. Dr. Baraka’s academic and professional contributions bridge clinical science, education, and digital innovation, emphasizing how AI, digital therapeutics, telemedicine, wearables, robotics, and virtual reality can enhance patient outcomes and reshape the future of healthcare delivery. He has delivered numerous keynote talks and workshops on digital transformation in healthcare and education, inspiring the next generation of clinicians to become technologically empowered and ethically grounded health professionals"

Dr. Myriam Abboud

(PhD, APD, RNutr, FHEA) | United Arab Emirates

Myriam has completed her PhD at the University of Sydney-School of Medicine and is currently Associate Professor at the College of Natural and Health Sciences at Zayed University, UAE. Myriam’s research focuses on investigating the link between vitamin D and non communicable diseases. She has published several papers in reputable peer-reviewed journals. Myriam is an Accredited Practicing Dietitian/Nutritionist. She completed her Masters in Nutrition and Dietetics at The University of Sydney. She started her career in Australia where she founded her own nutrition clinic specilising in Obesity and Diabetes management and offered nutrition and wellness counselling to individuals and corporations. She is a member of the Dietitians Association of Australia (DAA) and UK Association For Nutrition (AFN).

Dr. Nadia Almazroui

Vice President, International Pharmaceutical Federation (FIP) | Fellow, FIP President, Pharmacists Association – UAE | Associate Professor, University of Sharjah | United Arab Emirates

An Emirati pharmacy leader with 35+ years of transformative impact in clinical pharmacy, healthcare leadership, and global pharmaceutical policy. Elected Vice President of the International Pharmaceutical Federation (2025–2027) and awarded the prestigious FIP Fellowship (2025) for advancing pharmacy education, regulation, and practice worldwide. Currently President of the Pharmacists Association UAE, FIP EMR Forum, and ISPOR UAE Chapter, with extensive service in WHO Expert Committees. Associate Professor at University of Sharjah leading innovations in pharmacy education, pharmacoeconomics, digital health, and sustainability. Author of 60+ peer-reviewed publications, mentor, and advocate for women in science and pharmacy workforce development globally.

Dr. Nadine Z. Zeinab

Pharm. M.Sc. Chief Pharmacist at Emirates Specialty Hospital, DHCC. | United Arab Emirates

Ms. Zeinab is the Chief Pharmacist at Emirates Specialty Hospital, DHCC. She Leads the operational and clinical pharmacy excellence, strategic goals, regulatory governance of the pharmacy department ensuring safe, effective, and evidence-based medication management across the hospital. Adopts innovation and implements pharmacy practice improvements that ensure staff development and align with the hospital’s strategic goals, international, and national regulatory standards. She implements a structured medication safety program to minimize adverse drug events and optimize patient outcomes.With more than 15 years of experience in Pharmacy practice Ms. Zeinab is passionate about redefining the role of pharmacists in healthcare and bridging the gap between theory and real-world practice. Previously, Ms. Zeinab held key leadership roles as an Oncology Pharmacy Consultant and Pharmacy Practice Improvement Specialist at Clemenceau Medical Center Lebanon affiliated with Johns Hopkins Medicine International, Pharmacy Manager at Clemenceau Medical Centre Hospital in Dubai and Oncology Pharmacy Unit Manager/ Pain and Palliative Pharmacist at Clemenceau Medical Centre Lebanon. In these positions, she contributed significantly to the development of clinical pharmacy services, policies and procedures, accreditation preparation, team development, outpatient pharmacy service improvement, oncology pharmacy service establishment, and pain/palliative pharmacy service development. Ms. Zeinab has diverse pharmacy experience and holds multiple certifications in oncology pharmacy practice (both adult and pediatric), medication safety, international clinical pharmacy skills, pain management, palliative care, clean compounding techniques, pharmacy consultant, and healthcare quality. Ms. Zeinab is affiliated with the European Society of Oncology Pharmacy (ESOP) as a certified ESOP trainer and a member of the European Specialization in Oncology Pharmacy (EUSOP), contributing to the development and recording of several lectures in the European oncology pharmacy certification program.

Dr. Natalija Vuković

Consultant anesthesiologis | Serbia

Dr. Natalija is a Senior Consultant in Anesthesiology with Reanimatology and Intensive Care in Serbia and holds a Magister of Medical Sciences (MPhil) in Biochemistry. She has completed both the basic and teacher-level ESPEN examinations in Clinical Nutrition and Metabolism and serves as an Editor for Frontiers in Nutrition. She is a member of the Steering Committee of the National Society for Enteral and Parenteral Nutrition of Serbia and acts as the National Representative for countries with fewer than 25 members within the European Society of Intensive Care Medicine. Since October 2005, she has been practicing at the University Clinical Center Niš, Serbia

Dr. Omar Sulaiman

BCCCP , RCP Pharm D Critical care Clinical Pharmacist Head of clinical pharmacy services- KHUH" | Bahrain

Dr Omar sulaiman omar Abudulaziz, critical care clinical pharmacologist in king Hamad university Hospital – RMS, American board certified in critical care BCCCP ,received the Doctor of Pharmacy degree on 2017 From university of jordan, Head of clinical pharmacy services in king hamad university hospital (RMS) a member of the National quality and clinical committee in the supreme council of health and member of the British and National Antimicrobial stewardship committee (BSAC) board member of bahrain pharmacist society NHRA surveyor "

Dr. Reema Tayyem

Professor of Nutrition, Coordinator of Graduate Studies of the DNS,Chair of The 3rd Pediatric Nutrition Conference,Department of Nutrition Sciences,College of Health Sciences, Qatar Universit | Qatar

Professor of Nutrition, Department of Nutrition Sciences, College of Health Sciences, Qatar University, PO Box: 2713, Doha - Qatar Prof. Dr Reema Tayyem has a bachelor’s degree in Biochemistry and a master’s and PhD in Human Nutrition. She joined the Clinical Nutrition and Dietetics Dept at the Hashemite University in 2001 and moved to the Department of Nutrition and Food Technology at the University of Jordan in 2016. Dr Tayyem is now working in the Department of Nutrition Sciences at the College of Health Sciences at Qatar University. She was awarded a UNESCO-L'Oreal Fellowship for Young Women in Life Sciences in 2005. She did her post-doctoral studies at the University of California Cancer Center in San Diego/California/USA. She got research funding from various agencies in Qatar and Jordan. Her primary research interest is nutrition and dietary patterns associated with chronic diseases, including cancer, diabetes, cardiovascular disease and other diseases. Professor Tayyem has been invited to and attended numerous international, regional and national conferences and workshops. She has served on the editorial boards of several magazines. She has published more than 208 research papers in peer-reviewed scientific journals. Professor Tayyem has received many awards and honors

Dr. Saleh Alzahrani

Supply chain leader with 20+ years of experience optimizing complex, multi-site systems | Saudi Arabia

Saleh is a healthcare operation and supply chain leader with 20+ years of experience optimizing complex, multi-site systems. Known for translating strategy into measurable results, he has led enterprise-scale transformations, built high-performing teams, and embedded rigorous compliance across the lifecycle of care delivery. A data-driven innovator, Saleh advances resilience, cost efficiency, and clinical service continuity through analytics, process redesign, and supplier risk management. He regularly advises executive leadership on operating models, performance governance, and end-to-end supply chain modernization. At this conference, Saleh will share practical strategies for mitigating drug shortages and a proven control methodology.

Dr. Salwa Alsuwaidi

Consultant Internal Medicine & Geriatrics Director- Seniors’ Happiness Center. | United Arab Emirates

• Holds MRCP UK (Glasgow), FRCP, MRCP SCE Geriatrics, PhD Arab Board of Internal Medicine, Post Graduate Diploma of Gerontology & Geriatrics (Malta), Clinical Leadership Diploma from RCSI and a Professional Diploma in medicine for the older person from the Royal College of Physicians of Ireland. • Board member of the Middle East Academy for the Medicine of Ageing (MEAMA). • The president of Emirates Geriatric Society. • Clinical Instructor of Internal Medicine at MBRU. • Clinical Assistant Professor of Internal Medicine at MBRU.

Dr. Sameer Alzaidi

PharmD. MBAc, BCPS, BCIDP, AAHIVP | Saudi Arabia

Dr. Alzaidi completed his doctorate of pharmacy from Ohio Northern University, USA, in 2021. He then pursued a PGY1 and graduated in 2022 from Tufts Medicine Hospital, Boston. During his PGY1, Dr. Alzaidi fell in love with infectious diseases (ID) and decided to pursue a PGY2 at one of the largest healthcare systems in the United States, Intermountain Health. He is American board certified in pharmacotherapy and infectious diseases and hold a board certification in HIV from American Academy of HIV Medicine. He’s currently practicing as a consultant ID clinical pharmacist at Taif Health Cluster, SA. He is the head of IRB and clinical pharmacy Committees at Taif Health Cluster. His ID interests lie on PK/PD, MDROs, and immunocompromised population. He loves fungi and thinks it’s the most under-appreciated kingdom on earth.

Dr. Sherif Kamal

Advisor of the Chairman of EHA board for medication management and pharmacy affairs | Egypt

"Sherif Kamal is one of a second generation Egyptian clinical pharmacists, with more than 20 years of experience in this field, involved in the planning, designing and implementation of pharmaceutical care in oncology centers and hospitals as senior Clinical Pharmacy consultant. Sherif Kamal is the Advisor of the Chairman of EHA board for medication management and pharmacy affairs He earned his BS in Pharmacy 1998, an MSc in Clinical Pharmacy and is currently a PhD candidate at the Cairo University School of Pharmacy. Sherif has also completed a visiting fellowship at St. Jude’s Children Hospital in the United States in 2008. He is a certified Professional trainer by the AUC and made a healthcare management diploma in AUC with the thesis title :Pharmacy Digitalization - Drug Information and Pharmacy Resource Services For more than 20 years, Sherif has led a team that implemented clinical pharmacy services at various hospitals throughout Egypt and the region . He is the recipient the Egyptian Hospital Pharmacist Association Award and founder of the Egyptian Association of Clinical Pharmacists in 2010 He is a member of several international organizations including the International Society for Oncology Pharmacists, the European Society of Clinical Pharmacy, the American Society of Health-System Pharmacist, and the American College of Pharmacy. He is the Vize President of the European Society of Oncology Pharmacy Global for all Non-European countries. He is a member of the Board for International Accreditation of Hospital Pharmacy in ASHP He has conducted a wide variety of research studies involving the pharmacotherapeutics management of pediatric oncology diseases and presented his work at international meetings. Sherif is working with university of Colorado , American Society of Health system pharmacist ,American college of clinical Pharmacy ,American council for Pharmacy Education and European society if oncology Pharmacy to develop the pharmacy academy program for the health sciences Academy . We started Pharm D program, Residency program and many short courses. The program also introduced successfully the future of pharmacy which Is pharmacogenomics and personalized medication management. Sherif was the leading consultant working to implement clinical pharmacy in Egypt(4 Ministry of health Hoapitals;2 Military Hospitals and 3 Police Hospitals ) . Sherif is also leading an African initiative to improve healthcare via clinical pharmacy and medication management in Africa ,including Sudan,Ethiopia,Malawi , Uganda and Botswana. He was the first International Residency program director in the region and the first Pharm D program director in collaboration with Colrado run by a Hospital. His primary research interest focuses on pharmacy practice, patient safety, pharmacogentics, Pharmacoeconomics, pharmacovigilance , Green Pharmacy and the pharmaco-epidemiology of pediatric cancer. Sherif is also a professionally and practically qualified project manager in fundraising and business development, with more than 20 years of experience in this field, involved in the fundraising activity of the National Cancer Institute and Children's Cancer Hospital Foundation 57357. He is a Certified Lean Six Sigma Green Belt "

Dr. Sherry N. Nasralla

Lecturer, Pharmacy Program College of Health and Sport Sciences University of Bahrain | Bahrain

Ms. Sherry Nasralla is a lecturer at the Pharmacy Program, College of Health and Sport Sciences, University of Bahrain. She holds an M.Sc. in Pharmaceutical Sciences from Ain Shams University, Cairo Egypt; specializing in Pharmacology and Toxicology. Ms. Sherry has 20 years of undergraduate teaching experience and is a Fellow of Advance HE, UK. She has published several research articles in peer reviewed journals, as well as poster and oral presentations at various conferences. Her areas of research interest include pharmacy practice, education and workforce development.

Dr. Stavroula Theophanous-Kitiri

Chief Executive Officer (CEO) of The Breast Center of Cyprus and a Clinical Pharmacist specializing in oncology and patient‑safety systems | Cyprus

Stavroula Theophanous‑Kitiri is the Chief Executive Officer (CEO) of The Breast Center of Cyprus and a Clinical Pharmacist specializing in oncology and patient‑safety systems. She previously served as Director of Pharmacy at the Bank of Cyprus Oncology Centre from 1998 to 2025, where she led clinical services, medication‑safety initiatives, and multidisciplinary quality‑improvement programs that received national and international recognition. She is a Board Member of the European Society of Oncology Pharmacy (ESOP) and formerly served as ESOP Vice‑President for six years. She currently chairs ESOP Working Groups on Pain Management and Palliative Care. In Cyprus, she is President of the Pan‑Cyprian Association of Hospital Pharmacists (NOFAKY). She also serves on the Board of the Cyprus Institute of Neurology & Genetics and on the Advisory Board of the Pharmacy Program at the European University Cyprus. Across academia, Ms. Theophanous‑Kitiri has contributed to undergraduate and postgraduate teaching in Medicine and Pharmacy at the University of Cyprus, Frederick University, European University Cyprus, and St George’s, University of London medical program in Cyprus. Her educational work focuses on oncologic therapeutics, pharmacovigilance, safe‑handling of hazardous drugs, and pain management of cancer patients. Her current role at The Breast Center of Cyprus includes strategy, clinical‑operations leadership, and the development of multidisciplinary breast‑cancer pathways. She is actively involved in building digital quality infrastructures and fostering collaborations that connect surgery, oncology, pharmacy, radiology, nursing, and supportive care. A frequent invited speaker, she has delivered lectures and workshops on cancer pain, high‑alert medication systems, and patient‑centred opioid stewardship. Her work emphasizes practical, team‑based approaches that reduce preventable harm while improving function and quality of life for people living with and beyond cancer."

Dr. Tomoyuki Mizuno

PhD, FCP, Associate Professor of Pediatrics | USA

"Tomoyuki Mizuno, PhD, FCP, is an Associate Professor of Pediatrics in the Division of Translational and Clinical Pharmacology at Cincinnati Children’s Hospital Medical Center (CCHMC) and the University of Cincinnati College of Medicine. Dr. Mizuno also serves as director of the Pharmacometrics Center of Excellence Program and the Clinical Pharmacokinetics Consultation Service. Additionally, he holds a visiting professorship at Kyoto University, Japan. His research focuses on pharmacometrics, systems pharmacology, and artificial intelligence/machine learning (AI/ML)–driven precision dosing for pediatric patients. Dr. Mizuno also provides strategic clinical pharmacology and model-informed drug development (MIDD) consulting to pharmaceutical companies, supporting optimized clinical trial design and pediatric dose selection for FDA submissions. Dr. Mizuno has authored over 120 peer-reviewed publications and has been invited to speak at various national and international conferences. His work has been recognized with several prestigious awards, including the Victor Armstrong Young Investigator Award from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), the Young Scientist Award from Japan’s Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Tanabe Young Investigator Award from the American College of Clinical Pharmacology (ACCP). He currently serves as the Secretary of IATDMCT."

Dr. Wael Ahmed Eltayeb Osman

Dept. of Internal Medicine, | United Arab Emirates

Dr Wael Ahmed Eltayeb Osman is a Senior Consultant Pulmonologist at University Hospital Sharjah and an Adjunct Clinical Assistant Professor at the University of Sharjah Medical School. He completed his UK clinical training in Respiratory and General Internal Medicine and accumulated 16 years of clinical experience in the United Kingdom before relocating to the UAE four years ago. Dr Osman is a Fellow of the Royal College of Physicians of Edinburgh (RCPE) and the Royal College of Physicians and Surgeons of Glasgow (RCPSG). During his time in the UK, he was actively involved in asthma research, with particular focus on bronchial challenge models aimed at identifying novel inflammatory pathways. He contributed to multiple clinical trials, including Phase III studies involving patients with asthma and chronic obstructive pulmonary disease (COPD). In addition, he has presented abstracts at national and international respiratory conferences and has contributed to several pulmonology research projects. His primary clinical interests include chronic airway disease management, particularly asthma and COPD. Dr Osman advocates a holistic, precision-based approach to diagnosis and management, emphasising phenotype-directed and targeted therapies aimed at preventing disease progression, reducing exacerbations, and improving long-term outcomes. He also has a strong interest in physician and patient education, recognising its vital role in optimising disease control, improving adherence, reducing exacerbation risk, and empowering patients to actively participate in long-term respiratory disease management.

Dr. Wael Ali

President of the FIP Eastern Mediterranean Regional Pharmaceutical Forum (EMRpharm-FIP) for the 2025–2029 term and a member of the Executive Committee of the FIP Community Pharmacy Section | Egypt

"Dr. Wael K. Ali Ali Mazrouh is the President of the FIP Eastern Mediterranean Regional Pharmaceutical Forum (EMRpharm-FIP) for the 2025–2029 term and a member of the Executive Committee of the FIP Community Pharmacy Section (CPS). He also serves as the President of the Egyptian Organization of Pharmacy (EOP) and the President of PharmaHelp Foundation USA, a nonprofit public health research federation based in Virginia. With more than 24 years of experience in pharmacy, healthcare systems, and public health, Dr. Wael is recognized as a visionary leader in pharmacy transformation, education reform, and professional excellence. He has served as a speaker, moderator, and panelist at over 65 international conferences, summits, and workshops, addressing topics such as public health literacy, sustainability, and workforce development. He has co-authored major FIP publications, including “Improving Access to Safe and Quality Essential Medicines and Medical Devices” (2024) and “From Theory to Therapy: Balancing Evidence in Managing Common Ailments” (2025). Dr. Wael is currently pursuing two doctoral degrees a Doctor of Public Health (DrPH) at the American College of Education (USA) and a Doctorate in Business Administration (DBA) at the Arab Academy for Science, financial, and banking. He previously earned a Master of Business Administration (MBA) with distinction and a Master of Public Health (MPH) from the United States, both with honors. Recipient of more than 25 national and international awards, including the FIP Champion Award (2022) and the African Pharmaceutical Forum Award (2024), Dr. Wael continues to promote innovation, collaboration, and excellence in pharmacy education and practice across the Eastern Mediterranean Region and beyond.

Dr. Yanal Salam

HOD & Consultant Internal Medicine | United Arab Emirates

.

Dr. Yasmin Gamal El Gendy

MD, MSc, MBA, IBCLC, FAIMER Fellow | Egypt

Doctor Yasmin Gamal is Professor of Pediatrics and Clinical Nutrition in Ain shams university currently the director of children’s hospital Ain shams university ,she has 20 years of experience in Pediatric clinical nutrition acting as Member of the Nutrition Rehabilitation Unit Children’s Hospital, Ain Shams University 2004- till present Dr Yasmin a Board Member Of Clinical Nutrition Master Degree Ain Shams University ,pediatric nutrition consultant and instructor in AUC in Cairo, National Nutrition institute and Ministry of health she is Speaker in various international nutrition workshops and conferences related to field of clinical nutrition in pediatrics, She is also Clinical nutrition researcher with local and international publications , she Supervised more than 50 master degree and PHD thesis in Pediatrics related to the field of clinical nutrition and nutritional disorders Besides her MD in pediatrics ,she has European diploma in clinical nutrition(ESPEN) ,post graduate studies in pediatric clinical nutrition Boston university,certified international Lactation consultant , JCI diploma in health care quality,MBA and FAIMER fellow in medical education

Dr. Yasser Tashkandi

Consultant, Clinical Pharmacist, Consultant, Self-Development Trainer & Life Coach | Saudi Arabia

Consultant Clinical Pharmacist, and Consultant Trainer for Self-Development and Life Coach. With over 35 years of diverse experiences, Dr. Tashkandi have served in various positions within the healthcare sectors (education, awareness, training & self-development, in addition to mentoring and life coaching). Among his strong traits Dr. Tashkandi have demonstrated the ability to effectively communicate with various statuses of individuals, building and leading teams to achieve the organizations’ goals, and minimize challenges in work environment.

Dr. Zeid alkilani

President of Jordan pharmacist association (JPA) | Jordan

Dr. Zeid alkilani is a Chief Executive Officer and licensed pharmacist, holding a Master’s degree in Business Administration. He has an impressive track record of leadership achievements within the pharmaceutical sector. He currently serves as the President of the Jordan Pharmacists Association, where he plays a key role in advancing the pharmaceutical profession and supporting the growth of the healthcare sector. He is also a Board Member of the National Center for Human Rights and the Jordan Hashemite Charity Organization, reflecting his strong commitment to social responsibility and humanitarian causes. Recognized as a strategic thinker and an innovative leader, Dr.Zeid alkilani has demonstrated the ability to drive success across diverse professional environments. His contributions continue to shape and elevate the pharmacy profession on both national and regional levels.

Dr. Ziyad Almalki

Almalki’s Bio Ziyad Almalki, Professor of health economic and policy and Dean of development and quality | Saudi Arabia

Ziyad Almalki, Professor of health economic and policy and Dean of development and quality Dr. Almalki's academic foundation was laid at the prestigious King Saud University, where he earned a bachelor’s degree in pharmacy in 2008, establishing his roots in clinical practice. His career took a decisive turn with the pursuit of a Doctor of Philosophy in Health Outcomes from the University of Cincinnati's James L. Winkle College of Pharmacy, completed in 2017. Since January 2019, Dr. Almalki has served as a member of the SFDA's Pharmaceutical Products Pricing Committee. This committee holds a critical national mandate: to regulate the pricing of all pharmaceutical products in the Kingdom to ensure a delicate balance between affordability for the healthcare system, access for patients, and a fair market for pharmaceutical innovation. The committee's decisions directly impact the national healthcare budget and patient access to life-saving medicines. It employs a sophisticated methodology, considering a drug's therapeutic value, the availability of alternatives, robust economic studies, and international reference pricing from over a dozen developed countries. Dr. Almalki's Ph.D. in Health Outcomes and his extensive research portfolio in pharmacoeconomics make him an exceptionally qualified expert to contribute to these complex deliberations. Dr. Almalki also serves on the National Health Economics Advisory Committee of the Saudi Health Council. The SHC is a high-level coordinating body that aligns strategies across various government health entities to achieve national objectives. The advisory committee's focus is on providing strategic guidance on the economic sustainability of the entire health system. This includes advising on the transition to value-based healthcare, the implementation of health technology assessment, and other measures to ensure the financial viability of the sector—all of which are central pillars of the healthcare transformation agenda outlined in Vision 2030. Dr. Ziyad Almalki is a prolific and impactful researcher, having authored or co-authored over 115 peer-reviewed publications. His research agenda is not a purely academic pursuit but is strategically aligned with Saudi Arabia's most pressing health and economic challenges. He consistently generates the specific, localized evidence needed to inform the very policy bodies on which he serves. "